Page last updated: 2024-10-23

azathioprine and Irritable Bowel Syndrome

azathioprine has been researched along with Irritable Bowel Syndrome in 3 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Irritable Bowel Syndrome: A disorder with chronic or recurrent colonic symptoms without a clearcut etiology. This condition is characterized by chronic or recurrent ABDOMINAL PAIN, bloating, MUCUS in FECES, and an erratic disturbance of DEFECATION.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Segal, JP1
Mullish, BH1
Quraishi, MN1
Iqbal, TH1
Lahtinen, P1
Jalanka, J1
Hartikainen, A1
Mattila, E1
Hillilä, M1
Punkkinen, J1
Koskenpato, J1
Anttila, VJ1
Tillonen, J1
Satokari, R1
Arkkila, P1
Camilleri, M1
Saito, YA1

Reviews

1 review available for azathioprine and Irritable Bowel Syndrome

ArticleYear
Pharmacogenomics in gastrointestinal disorders.
    Methods in molecular biology (Clifton, N.J.), 2008, Volume: 448

    Topics: Antineoplastic Agents; Azathioprine; Biotransformation; Colorectal Neoplasms; Gastrointestinal Agent

2008

Other Studies

2 other studies available for azathioprine and Irritable Bowel Syndrome

ArticleYear
Letter: faecal microbiota transplantation for IBS.
    Alimentary pharmacology & therapeutics, 2020, Volume: 52, Issue:3

    Topics: Azathioprine; Fecal Microbiota Transplantation; Feces; Gastrointestinal Microbiome; Humans; Irritabl

2020
Letter: faecal microbiota transplantation for irritable bowel syndrome. Authors' reply.
    Alimentary pharmacology & therapeutics, 2020, Volume: 52, Issue:3

    Topics: Anemia; Azathioprine; Fecal Microbiota Transplantation; Humans; Irritable Bowel Syndrome; Leukopenia

2020